Tesamorelin – 10mg – 20mg

Description

Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) and is widely studied for its role in receptor-mediated signaling within growth hormone-related pathways. It is commonly examined in research involving peptide-driven communication, signaling cascade activation, and regulatory pathway interactions.

In laboratory settings, tesamorelin is utilized to investigate its interaction with GHRH receptors and its influence on downstream signaling pathways associated with peptide-mediated communication. Its structure is designed to provide enhanced stability compared to native GHRH, making it a useful compound in controlled experimental models focused on signaling dynamics and pathway modulation.

Tesamorelin has been explored in research involving:

• Growth hormone-releasing hormone (GHRH) receptor interaction
• Peptide-mediated signaling cascade activation
• Regulatory pathway modeling and communication systems
• Receptor binding dynamics and signaling efficiency
• Growth hormone-related pathway studies in controlled environments

Due to its targeted receptor activity and improved stability, tesamorelin is frequently used in research examining GHRH pathway signaling and peptide-driven communication systems.

Each vial contains lyophilized tesamorelin intended strictly for laboratory research purposes.

Research Use Only (RUO). Not for human or veterinary use.